Hannah Clarke

home / authors / hannah-clarke

Articles

Image of a doctor with an illustration of a bladder.

Padcev Plus Keytruda Doesn’t Worsen Quality of Life in Bladder Cancer

Hannah Clarke
June 7th 2024

Padcev and Keytruda improve survival and progression among patients with bladder cancer, but don’t adversely impact pain, functioning or quality of life.

Models On screen, drawing illustrating the prostate (without pathology) | Image credit: © RFBSIB - © stock.adobe.com

Pluvicto Plus Xtandi Enhances Anti-Tumor Activity for Some Patients With Prostate Cancer

Hannah Clarke
October 27th 2023

Data presented at ESMO “provides strong evidence for an enhanced anti-cancer effect with the combination” of Pluvicto and Xtandi, according to one expert.

Medical doctor drawing prostate cancer on the virtual screen. | Image credit: © WrightStudio - © stock.adobe.com

Side Effects Manageable From Talzenna/Xtandi Treatment in Prostate Cancer Subset

Hannah Clarke
June 5th 2023

Side effects such as anemia and other blood-related events were resolved with dose reductions and/or supportive care in men with metastatic castration-resistant prostate cancer.

Latest Updated Articles

The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma: © stock.adobe.com.
Published: April 24th 2025 | Updated: April 27th 2025
FDA Approves Penpulimab-kcqx For Nasopharyngeal Carcinoma
People can help EBCI reach their goal of $20,000 dollars raised for GiveBIG 2025 by giving at endbraincancer.org/donate: © stock.adobe.com.
Published: April 22nd 2025 | Updated: April 27th 2025
Support Patient Access and Education with the End Brain Cancer Initiative for GiveBIG 2025
The End Brain Cancer Initiative is currently seeking Primary Central Nervous System Lymphoma patients and care partners to participate in an online roundtable discussion: © stock.adobe.com.
Published: March 3rd 2025 | Updated: April 27th 2025
Primary Central Nervous System Lymphoma Patient and Care Partner Roundtable Hosted by the End Brain Cancer Initiative
Registration is now open for the 2025 Know All Your Treatment Options (KAYTO25) online patient disease education event/webinar: © stock.adobe.com.
Published: March 17th 2025 | Updated: April 27th 2025
Registration Open for the 2025 Know All Your Treatment Options Webinar Hosted by the End Brain Cancer Initiative
Each May, for over a decade, the End Brain Cancer Initiative (EBCI) has presented the National HOPE Award to a brain cancer patient who deeply inspires us: © stock.adobe.com.
Published: March 18th 2025 | Updated: April 27th 2025
Nominations Open for the End Brain Cancer Initiative’s 2025 National Patient Disease Education Initiative and HOPE Award
Illustration of bladder.
Published: April 22nd 2025 | Updated: April 27th 2025
Imfinzi Combination Shows Efficacy in Bladder Cancer Treatment